These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7886411)

  • 1. Absorption characteristics of lignocaine following intravesical instillation.
    Birch BR; Miller RA
    Scand J Urol Nephrol; 1994 Dec; 28(4):359-64. PubMed ID: 7886411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lignocaine levels during transurethral prostatectomy.
    Eardley I; Broome GD; Murray A; Ramsay JW; Whitfield HN; Wilkinson DJ
    Ann R Coll Surg Engl; 1989 Sep; 71(5):278-80. PubMed ID: 2802473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood concentration of lignocaine after application of 2% lignocaine gel in the urethra.
    Axelsson K; Jozwiak H; Lingårdh G; Schönebeck J; Widman B
    Br J Urol; 1983 Feb; 55(1):64-8. PubMed ID: 6824867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic changes during therapeutic intravesical instillations of capsaicin.
    Chandiramani VA; Peterson T; Duthie GS; Fowler CJ
    Br J Urol; 1996 Jun; 77(6):792-7. PubMed ID: 8705210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.
    Burm AG; Vermeulen NP; van Kleef JW; de Boer AG; Spierdijk J; Breimer DD
    Clin Pharmacokinet; 1987 Sep; 13(3):191-203. PubMed ID: 3665324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intravesical device for the sustained delivery of lidocaine to the bladder.
    Lee H; Cima MJ
    J Control Release; 2011 Jan; 149(2):133-9. PubMed ID: 20971144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration after instilling 2% lignocaine gel into the urethra.
    Mets B; von Oppell UO
    S Afr Med J; 1993 Feb; 83(2):134-5. PubMed ID: 8451695
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycopyrronium prolongs topical anaesthesia of oral mucosa and enhances absorption of lignocaine.
    Watanabe H; Lindgren L; Rosenberg P; Randell T
    Br J Anaesth; 1993 Jan; 70(1):94-5. PubMed ID: 8431344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical lignocaine and detrusor instability.
    Higson RH; Smith JC; Hills W
    Br J Urol; 1979 Dec; 51(6):500-3. PubMed ID: 534832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic absorption of lignocaine ointment from tracheal tubes.
    Sellers WF; Dye A; Harvey J
    Anaesthesia; 1985 May; 40(5):483-5. PubMed ID: 4014626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient comfort and plasma lignocaine concentrations during fibreoptic bronchoscopy.
    Sutherland AD; Santamaria JD; Nana A
    Anaesth Intensive Care; 1985 Nov; 13(4):370-4. PubMed ID: 4073449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability of intranasal lignocaine.
    Scavone JM; Greenblatt DJ; Fraser DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):722-4. PubMed ID: 2611092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal anaesthesia for pelvic surgery: low concentrations of lignocaine and bupivacaine are effective with less adverse events.
    Punj J; Khan RM
    Middle East J Anaesthesiol; 2013 Feb; 22(1):71-7. PubMed ID: 23833854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lignocaine plasma levels following topical gel application in laparoscopic and hysteroscopic procedures.
    Hewitt EA; Armstrong G; Beg N; Katz S; Vancaillie TG
    Anaesth Intensive Care; 2012 Mar; 40(2):292-6. PubMed ID: 22417024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of lignocaine during fibreoptic bronchoscopy.
    Efthimiou J; Higenbottam T; Holt D; Cochrane GM
    Thorax; 1982 Jan; 37(1):68-71. PubMed ID: 7071796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal absorption of a liposome-encapsulated formulation of lidocaine following topical administration in cats.
    Fransson BA; Peck KE; Smith JK; Anthony JA; Mealey KL
    Am J Vet Res; 2002 Sep; 63(9):1309-12. PubMed ID: 12224866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
    Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
    Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of KRP-116D, a 50% w/w dimethyl sulfoxide aqueous solution, on the systemic absorption from bladder by intravesical instillation in healthy Japanese subjects.
    Shimada H; Yono M; Hojo Y; Hamamura Y; Ootsuki A
    Low Urin Tract Symptoms; 2020 May; 12(2):150-154. PubMed ID: 31696635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of lignocaine and its metabolites during fibreoptic bronchoscopy.
    Jones DA; McBurney A; Stanley PJ; Tovey C; Ward JW
    Br J Anaesth; 1982 Aug; 54(8):853-7. PubMed ID: 7104134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.